Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.

PubWeight™: 2.53‹?› | Rank: Top 2%

🔗 View Article (PMC 4226221)

Published in JAMA on November 20, 2013

Authors

Seth S Martin1, Michael J Blaha, Mohamed B Elshazly, Peter P Toth, Peter O Kwiterovich, Roger S Blumenthal, Steven R Jones

Author Affiliations

1: Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.

Associated clinical trials:

The Very Large Database of Lipids (VLDL) (VLDL) | NCT01698489

A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism | NCT02366156

Articles citing this

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J (2016) 0.93

Are we moving towards concordance on the principle that lipid discordance matters? Circulation (2013) 0.84

Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial. Circulation (2015) 0.83

Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol. N Am J Med Sci (2014) 0.80

Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011. PLoS One (2016) 0.80

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016. Arch Med Sci (2016) 0.80

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovasc Diabetol (2014) 0.79

Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo. Lipids Health Dis (2016) 0.78

Measured versus calculated LDL-cholesterol in subjects with type 2 diabetes. Pak J Med Sci (2016) 0.78

Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies. World J Cardiol (2016) 0.78

Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B). Circulation (2015) 0.77

Comparison and Validation of 10 Equations Including a Novel Method for Estimation of LDL-cholesterol in a 168,212 Asian Population. Medicine (Baltimore) (2016) 0.77

What's new with measuring cholesterol? JAMA (2013) 0.76

[What are the advantages of the modified Friedewald equation?--Modified Friedwald equation measures LDL-cholesterol more exactly]. Dtsch Med Wochenschr (2014) 0.75

Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis. J Lipids (2016) 0.75

Accuracy of low-density lipoprotein cholesterol estimation at very low levels. BMC Med (2017) 0.75

Anthropometric and metabolic indices in assessment of type and severity of dyslipidemia. J Physiol Anthropol (2017) 0.75

The early years of lipoprotein research: from discovery to clinical application. J Lipid Res (2016) 0.75

Positioning about the Flexibility of Fasting for Lipid Profiling. Arq Bras Cardiol (2017) 0.75

Comparison of Formulas for Calculating Low-density Lipoprotein Cholesterol in General Population and High-risk Patients with Cardiovascular Disease. Korean Circ J (2016) 0.75

Lipid Variables Related to the Extent and Severity of Coronary Artery Disease in Non-Diabetic Turkish Cypriots. Iran J Public Health (2015) 0.75

Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients. J Atheroscler Thromb (2016) 0.75

Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study. J Clin Endocrinol Metab (2017) 0.75

Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean J Fam Med (2017) 0.75

Articles cited by this

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51

Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med (2012) 5.80

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol (2009) 5.65

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 4.09

Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 3.09

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation (2008) 3.03

National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem (1995) 2.96

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86

A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort. Ann Clin Biochem (2012) 2.84

The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA (2012) 2.69

Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol (2005) 2.23

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol (2013) 2.15

Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA (2009) 2.10

A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA (1986) 1.80

Cholesterol profile measurement by vertical auto profile method. Clin Lab Med (2006) 1.46

Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.43

The importance of potential studies that have not existed and registration of observational data sets. JAMA (2012) 1.34

A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis (2010) 1.25

Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis (1998) 1.24

Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods. Clin Chem (1988) 1.17

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 1.12

The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med (2008) 1.09

Individual variation in serum cholesterol levels. Proc Natl Acad Sci U S A (1987) 1.04

Very large database of lipids: rationale and design. Clin Cardiol (2013) 0.96

Cardiovascular risk assessment in the 21st century. JAMA (2012) 0.95

Should we fast before we measure our lipids? Arch Intern Med (2012) 0.89

Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia. Clin Chem (1999) 0.81

Articles by these authors

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation (2006) 7.16

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med (2015) 4.18

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet (2011) 4.06

Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics (2012) 3.98

Clinical practice. Low HDL cholesterol levels. N Engl J Med (2005) 3.81

Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2009) 3.73

Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA (2003) 3.64

Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging (2009) 3.23

Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75

Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med (2007) 2.62

Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. Arch Intern Med (2011) 2.45

Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations. Circulation (2002) 2.42

Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol (2008) 2.39

Association between high-sensitivity C-reactive protein and coronary plaque subtypes assessed by 64-slice coronary computed tomography angiography in an asymptomatic population. Circ Cardiovasc Imaging (2011) 2.27

Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J (2006) 2.22

Association of resting heart rate with carotid and aortic arterial stiffness: multi-ethnic study of atherosclerosis. Hypertension (2013) 2.18

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol (2013) 2.15

The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2010) 2.15

Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol (2010) 2.11

Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis Rheumatol (2015) 2.07

Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 2.06

Prevalence of and risk factors for subclinical cardiovascular disease in selected US Hispanic ethnic groups: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2008) 2.04

Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation (2005) 2.03

Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol (2007) 1.99

Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol (2010) 1.92

Making the case for selective use of statins in the primary prevention setting. Arch Intern Med (2011) 1.90

Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study. J Am Coll Cardiol (2009) 1.89

Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc (2013) 1.89

Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis (2005) 1.87

Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging (2012) 1.85

Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2010) 1.85

A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis (2013) 1.84

Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials. J Am Coll Cardiol (2012) 1.82

Abdominal aortic calcium and multi-site atherosclerosis: the Multiethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.79

Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis. Hypertension (2010) 1.75

Arterial age as a function of coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol (2008) 1.74

The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med (2008) 1.73

Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2011) 1.72

Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.72

Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.71

Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2009) 1.71

Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis (2008) 1.71

Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history. Circulation (2004) 1.71

Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol (2010) 1.69

General Cardiovascular Risk Profile identifies advanced coronary artery calcium and is improved by family history: the multiethnic study of atherosclerosis. Circ Cardiovasc Genet (2009) 1.68

Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years. J Pediatr (2010) 1.64

Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum (2010) 1.63

Association of traditional cardiovascular risk factors with coronary plaque sub-types assessed by 64-slice computed tomography angiography in a large cohort of asymptomatic subjects. Atherosclerosis (2009) 1.60

Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. Acad Radiol (2006) 1.59

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.58

Thoracic aortic calcification and coronary heart disease events: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2010) 1.53

Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol (2013) 1.52

Relationship of aortic valve calcification with coronary artery calcium severity: the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Comput Tomogr (2009) 1.52

Aspirin and clopidogrel resistance. Mayo Clin Proc (2006) 1.52

Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J (2009) 1.51

The relationship between resting heart rate and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2011) 1.50

Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 1.50

Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol (2011) 1.50

A summary of results of the Dietary Intervention Study in Children (DISC): lessons learned. Prog Cardiovasc Nurs (2003) 1.48

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol (2011) 1.45

Perceived racial/ethnic discrimination, smoking and alcohol consumption in the Multi-Ethnic Study of Atherosclerosis (MESA). Prev Med (2010) 1.45

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens (2015) 1.45

Increased level of cardiorespiratory fitness blunts the inflammatory response in metabolic syndrome. Int J Cardiol (2005) 1.45

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol (2013) 1.44

Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 1.44

Hypertension care and control in underserved urban African American men: behavioral and physiologic outcomes at 36 months. Am J Hypertens (2003) 1.44

Delayed heart rate recovery is strongly associated with early and late-stage prehypertension during exercise stress testing. Am J Hypertens (2013) 1.43

Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.43

Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia. Clin Ther (2016) 1.39

A simplified approach to the management of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 1.39

Relation of C-reactive protein to abdominal adiposity. Am J Cardiol (2010) 1.38

Coronary artery calcification score is an independent predictor of the no-reflow phenomenon after reperfusion therapy in acute myocardial infarction. Coron Artery Dis (2015) 1.38